MoonLake Immunotherapeutics MLTX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $298.49M-10.8% | $334.52M-4.6% | $350.7M+14.3% | $306.7M+12.9% | $271.6M+50.5% | ||
| $59.43M0.0% | $59.45M+99.9% | $29.74M-74.9% | $118.4M-43.2% | $208.56M-22.1% | ||
| $1.61M+43.9% | $1.12M-20.8% | $1.41M+5.5% | $1.34M+31.8% | $1.01M+124% | ||
| $396.64M-5.9% | $421.69M+2.5% | $411.22M-9.7% | $455.48M-10.0% | $506.26M+6.7% | ||
| $532K-7.8% | $577K-7.2% | $622K-6.7% | $667K-6.2% | $711K-1.5% | ||
| 6.4%+1.8% | 4.6%-0.1% | 4.7%0.0% | 4.7%0.0% | 4.7%-292,199,995% | ||
| $1.34M+126% | $596K+1.5% | $587K-65.4% | $1.7M-0.1% | $1.7M— | ||
| $3.73M+36.3% | $2.74M-12.2% | $3.12M-32.4% | $4.62M-7.7% | $5M+37.2% | ||
| $400.37M-5.7% | $424.43M+2.4% | $414.34M-9.9% | $460.1M-10.0% | $511.26M+7.0% | ||
| $2.2M-5.6% | $2.32M-44.7% | $4.2M+29.8% | $3.23M+27.4% | $2.54M-79.0% | ||
| $920K-25.4% | $1.23M-17.7% | $1.5M-3.3% | $1.55M+8.2% | $1.43M+4.4% | ||
| $1.4M+27.5% | $1.09M+7.9% | $1.01M+21.3% | $836K-62.5% | $2.23M+248% | ||
| $46.11M+1.4% | $45.48M-6.0% | $48.37M+76.8% | $27.36M+14.1% | $23.98M+6.8% | ||
| $99.02M+33.6% | $74.1M+0.5% | $73.74M+0.5% | $73.38M+0.5% | $73.02M— | ||
| $865K+131% | $374K-23.0% | $486K-41.9% | $836K-26.8% | $1.14M-21.7% | ||
| $1.79M+11.0% | $1.61M-19.0% | $1.99M-16.8% | $2.39M-7.3% | $2.57M-9.0% | ||
| $100.24M+34.6% | $74.47M-0.4% | $74.78M0.0% | $74.79M+0.1% | $74.7M+3,493% | ||
| $146.35M+22.0% | $119.95M-2.6% | $123.14M+20.5% | $102.15M+3.5% | $98.68M+302% | ||
| $786.31M+2.5% | $766.78M+11.3% | $689.11M+0.8% | $683.96M+0.5% | $680.66M+0.5% | ||
| -$532.62M-15.1% | -$462.91M-15.6% | -$400.49M-21.1% | -$330.76M-20.0% | -$275.54M-17.0% | ||
| $322K-46.7% | $604K+117% | $278K-46.5% | $520K-78.2% | $2.39M-52.2% | ||
| $254.02M-16.6% | $304.48M+5.4% | $288.91M-18.3% | $353.73M-13.2% | $407.52M-8.8% | ||
| $400.37M-5.7% | $424.43M+2.4% | $414.34M-9.9% | $460.1M-10.0% | $511.26M+7.0% | ||
| $59.07M-0.2% | $59.17M+102% | $29.26M-75.1% | $117.66M-42.9% | $205.91M-36.0% | ||
| $59.43M0.0% | $59.45M+99.9% | $29.74M-74.9% | $118.4M-43.2% | $208.56M-36.3% | ||
| $59.43M0.0% | $59.45M+99.9% | $29.74M-74.9% | $118.4M-43.2% | $208.56M-22.1% | ||
| $357.9M— | —— | —— | —— | —— | ||
| $5.76M+18.4% | $4.87M+21.1% | $4.02M+18.0% | $3.41M+14.1% | $2.99M+5.1% | ||
| $5.76M+18.4% | $4.87M+21.1% | $4.02M+18.0% | $3.41M+14.1% | $2.99M+5.1% | ||
| $1.34M+126% | $596K+1.5% | $587K-65.4% | $1.7M-0.1% | $1.7M— | ||
| $59.07M-0.2% | $59.17M+102% | $29.26M-75.1% | $117.66M-42.9% | $205.91M-36.0% | ||
| $1.86M+18.6% | $1.57M-18.1% | $1.91M-15.1% | $2.25M-13.1% | $2.59M-11.4% | ||
| $1.34M+129% | $587K0.0% | $587K-65.4% | $1.7M-0.1% | $1.7M— | ||
| $1.86M+18.6% | $1.57M-18.1% | $1.91M-15.1% | $2.25M-13.1% | $2.59M-11.4% | ||
| $1.34M+126% | $596K+1.5% | $587K-65.4% | $1.7M-0.1% | $1.7M— | ||
| $1.86M+18.6% | $1.57M-18.1% | $1.91M-15.1% | $2.25M-13.1% | $2.59M-11.4% | ||
| $1.34M+126% | $596K+1.5% | $587K-65.4% | $1.7M-0.1% | $1.7M— | ||
| $2.2M-5.6% | $2.32M-44.7% | $4.2M+29.8% | $3.23M+27.4% | $2.54M-40.1% | ||
| $1.4M+27.5% | $1.09M+7.9% | $1.01M+21.3% | $836K-62.5% | $2.23M+248% | ||
| $2.2M-5.6% | $2.32M-44.7% | $4.2M+29.8% | $3.23M+27.4% | $2.54M-40.1% | ||
| $23.38M-20.9% | $29.55M+16.9% | $25.28M+48.0% | $17.08M+42.3% | $12.01M+33.5% | ||
| $875K— | —— | $400K-50.7% | $811K-28.6% | $1.14M— | ||
| $458K— | —— | $147K0.0% | $147K+8.1% | $136K— | ||
| $458K— | —— | $100K0.0% | $100K+8.7% | $92K— | ||
| $458K— | —— | $147K0.0% | $147K+8.1% | $136K— | ||
| $98K— | —— | $147K0.0% | $147K+8.1% | $136K— | ||
| $487K— | —— | $1.27M-1.2% | $1.29M+7.4% | $1.2M— | ||
| $1.92M— | —— | $2.06M-17.1% | $2.49M-7.7% | $2.7M— | ||
| $133K— | —— | $79K-24.0% | $104K-15.4% | $123K— | ||
| $100M+33.3% | $75M0.0% | $75M0.0% | $75M0.0% | $75M— | ||
| $5.94M+31.4% | $4.52M+346% | $1.01M-5.3% | $1.07M-5.0% | $1.13M— | ||
| $353K— | $0-100% | $549K-4.4% | $574K+7.1% | $536K-13.7% | ||
| $98K— | —— | $147K0.0% | $147K+8.1% | $136K— | ||
| $98K— | —— | $147K0.0% | $147K+8.1% | $136K— | ||
| $21.81M+48.5% | $14.69M-31.9% | $21.59M+147% | $8.73M-17.2% | $10.54M-12.9% | ||
| $100.8M+33.1% | $75.71M0.0% | $75.73M-0.1% | $75.77M+0.2% | $75.6M+2,572% | ||
| $11.29— | —— | —— | —— | $41.77— | ||
| $362K+27.0% | $285K-41.5% | $487K-34.5% | $743K-72.0% | $2.65M-51.0% | ||
| $59.07M-0.2% | $59.17M+102% | $29.26M-75.1% | $117.66M-42.9% | $205.91M-36.0% | ||
| $363K-15.6% | $430K+2.9% | $418K+8.3% | $386K-53.7% | $833K+42.2% | ||
| $8.68M+105% | $4.23M-60.4% | $10.68M+279% | $2.82M-30.8% | $4.07M+101% | ||
| $9.18M+38.7% | $6.62M+42.7% | $4.64M+406% | $917K+257% | $257K-94.3% | ||
| $362K+27.0% | $285K-41.5% | $487K-34.5% | $743K-72.0% | $2.65M-51.0% | ||
| $59.07M-0.2% | $59.17M+102% | $29.26M-75.1% | $117.66M-42.9% | $205.91M-36.0% | ||
| $59.43M0.0% | $59.45M+99.9% | $29.74M-74.9% | $118.4M-43.2% | $208.56M-36.3% | ||
| 3,363.9%— | —— | 3,363.9%0.0% | 3,363.9%0.0% | 3,363.9%— | ||
| $350.5M— | —— | $362.8M-15.3% | $428.1M-11.2% | $482.3M— | ||
| $4.96M+37.0% | $3.62M+2.6% | $3.53M+2.7% | $3.43M— | —— | ||
| $100M+33.3% | $75M0.0% | $75M0.0% | $75M0.0% | $75M— | ||
| $5.94M+31.4% | $4.52M— | —— | —— | —— | ||
| $353K— | $0-100% | $549K-4.4% | $574K+7.1% | $536K-13.7% | ||
| $1.92M— | —— | $2.06M-17.1% | $2.49M-7.7% | $2.7M— | ||
| $0— | —— | —— | —— | —— | ||
| $133K— | —— | $79K-24.0% | $104K-15.4% | $123K— | ||
| $2.39M+11.5% | $2.14M-15.4% | $2.53M-13.2% | $2.92M-11.6% | $3.3M-9.4% | ||
| $0.06+39.1% | $0.05-2.1% | $0.050.0% | $0.050.0% | $0.050.0% | ||
| $32.96M+44.2% | $22.86M-14.4% | $26.71M-1.0% | $26.99M+16.6% | $23.15M-1.2% | ||
| $551K-37.8% | $886K-14.5% | $1.04M-22.5% | $1.34M+72.3% | $776K-30.3% | ||
| $16.33M-5.9% | $17.36M-1.2% | $17.58M+1.6% | $17.3M+20.9% | $14.31M+1.2% | ||
| $11.29— | —— | —— | —— | $41.77— | ||
| $14.47M+314% | $3.49M-47.8% | $6.69M-4.6% | $7.02M-0.5% | $7.05M-8.6% | ||
| $175.7M— | —— | $191M-14.7% | $223.9M+8.9% | $205.6M— | ||
| $875K— | —— | $400K-50.7% | $811K-28.6% | $1.14M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MoonLake Immunotherapeutics's total assets?
- MoonLake Immunotherapeutics (MLTX) holds $400.4M in total assets, down 21.7% year over year.
- How much debt does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics carries $100.8M in total debt against $254.0M of shareholders' equity, a debt-to-equity ratio of 0.40.
- How much cash does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics holds $298.5M in cash and equivalents.
- Can MoonLake Immunotherapeutics cover its short-term obligations?
- Its current ratio is 8.60 — current assets exceed current liabilities.
- Where does MoonLake Immunotherapeutics's balance sheet data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.